New research in mice shows that curli amyloid fibers from Salmonella and E. coli biofilms can drive the production of ...

A finely ground powder of the traditional Chinese herb Astragalus membranaceus significantly boosted the complement regulator C4bp and antibody IgM in weaned goat kids without triggering inflammation, ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, will present new data from across its portfolio and pipeline at the 2026 American Association ...

Boost ROI with mechanism-led programs, early safety and biomarker plans, validated assays, disciplined partner selection, responsible AI, data integrity and supply contingenciesDublin, Sept. (GLOBE ...

Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today ...

A controlled feeding trial reveals striking differences in how refined starch and added sugar affect immune cells after substantial weight loss on a very-low-carbohydrate diet. Study: Effects of ...

Annexon has announced the publication of a peer-reviewed study examining its investigational therapy tanruprubart for Huntington disease. Published in the journal Movement Disorders, this research ...

Complement pathway proteins are involved in immunoglobulin A-containing immune complex (IgA-IC) formation and deposition in the kidneys. Elevated complement factor H-related protein 1 (CFHR1) may be a ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...